Temazepam
Active substance: temazepam
CAPSULE · TEMAZEPAM 30 mg/1
United StatesActive
Marketing holder: Amneal Pharmaceuticals LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TEMAZEPAM · 30 mg/1
Import and control
Control by country
- United StatescontrolledSchedule: CIV
Source: openFDA NDC · record 01a1208c-41fc-75ff-8664-a302cfb6337d,01a1208c-6c26-73b4-ab62-13263076da0d,01a1208c-9310-7b0c-a85d-760ced938bc1,01a1208c-985c-7b8f-98a1-3ec6bbcccb72,01a1208c-9b7f-7d2b-b743-c8fdf1f8344f;count=88 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 65162-557
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIV
- Route
- ORAL
Sources
- product · openFDA NDC · 65162-557 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 65162-557 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 65162-557 · Verified 2026-10-09 · open in source